Calogero Pagliarello
Trento, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 68 publications
Baricitinib versus ritlecitinib for severe alopecia areata: A 24-week real-world study.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: April 11, 2026
Stepwise topical corticosteroid and dexamethasone rescue strategy enhances baricitinib outcomes in severe alopecia areata: real-life clinical experience.
Journal: European journal of dermatology : EJD
Published: March 23, 2026
Response to Zhang X et al's "Effectiveness and tolerability of baricitinib with or without prior corticosteroids in alopecia areata: A retrospective cohort study".
Journal: Journal of the American Academy of Dermatology
Published: February 18, 2026
Clinical and Mechanistic Evidence for Comano Thermal Water: A Narrative Review.
Journal: International journal of molecular sciences
Published: February 05, 2026
Calibration markers enable lesion measurement in total body photography.
Journal: Journal of the American Academy of Dermatology
Published: January 20, 2026
Ritlecitinib for Severe Alopecia Areata: A 24-Week, Multicentre, Real-World Study.
Journal: American journal of clinical dermatology
Published: November 05, 2025
Complementing baricitinib response in late-responding alopecia areata through alternating weekly double combination of topical corticosteroids: A split-scalp comparison.
Journal: JAAD case reports
Published: July 28, 2025
A simulation-based strategy to prioritize melanoma excision in secondary care.
Journal: Journal of the American Academy of Dermatology
Published: April 29, 2025
Effectiveness and safety of baricitinib in severe alopecia areata: 48-week results.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: February 28, 2025
Self-detected Melanomas are Thicker Regardless of Patient's Complexity: A Retrospective Analysis.
Journal: Acta dermato-venereologica
Published: December 19, 2022
Eruptive basal cell carcinoma and lenalidomide: rising awareness among dermatologists.
Journal: Dermatology reports
Published: May 25, 2022
Last Updated: 09/26/2026